SWKH RSI Chart
Last 7 days
-0.5%
Last 30 days
-1.5%
Last 90 days
0.7%
Trailing 12 Months
-3.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 40.6M | 39.6M | 38.7M | 37.8M |
2022 | 52.5M | 48.8M | 45.2M | 41.5M |
2021 | 41.6M | 46.4M | 51.3M | 56.2M |
2020 | 32.7M | 34.7M | 0 | 36.7M |
2019 | 28.6M | 27.4M | 29.1M | 30.7M |
2018 | 29.4M | 30.1M | 30.5M | 26.0M |
2017 | 32.0M | 29.5M | 30.7M | 37.5M |
2016 | 22.9M | 26.1M | 24.6M | 22.4M |
2015 | 19.5M | 21.6M | 23.6M | 23.5M |
2014 | 9.7M | 12.0M | 14.2M | 17.4M |
2013 | 1.1M | 2.0M | 3.5M | 6.4M |
2012 | 244.0K | 220.0K | 205.0K | 682.0K |
2011 | 468.5K | 407.0K | 345.5K | 284.0K |
2010 | 0 | 0 | 0 | 530.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | albright jerry | acquired | 13,757 | 16.88 | 815 | - |
Apr 01, 2024 | hatcher robert k. | acquired | 13,757 | 16.88 | 815 | - |
Apr 01, 2024 | pennington marcus edward | acquired | 31,498 | 16.88 | 1,866 | - |
Apr 01, 2024 | dotter laurie l. | acquired | 13,757 | 16.88 | 815 | - |
Mar 01, 2024 | staggs joe david jr | acquired | - | - | 35,881 | president |
Jan 02, 2024 | hatcher robert k. | acquired | 13,749 | 17.95 | 766 | - |
Jan 02, 2024 | pennington marcus edward | acquired | 27,499 | 17.95 | 1,532 | - |
Jan 02, 2024 | dotter laurie l. | acquired | 13,749 | 17.95 | 766 | - |
Jan 02, 2024 | albright jerry | acquired | 13,749 | 17.95 | 766 | - |
Oct 02, 2023 | pennington marcus edward | acquired | 31,509 | 15.85 | 1,988 | - |
Which funds bought or sold SWKH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 12, 2024 | Dynamic Advisor Solutions LLC | added | 0.31 | -785 | 389,128 | 0.01% |
Apr 05, 2024 | CWM, LLC | sold off | -100 | -1,000 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.54 | 421,820 | 3,967,320 | -% |
Mar 05, 2024 | GREENWOOD CAPITAL ASSOCIATES LLC | added | 94.82 | 838,161 | 1,555,540 | 0.10% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 101 | 261,979 | 473,486 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -2.5 | 2,521 | 32,115 | -% |
Feb 15, 2024 | BARCLAYS PLC | added | 434 | 77,000 | 92,000 | -% |
Feb 15, 2024 | Farther Finance Advisors, LLC | new | - | 263 | 263 | -% |
Feb 15, 2024 | SkyView Investment Advisors, LLC | sold off | -100 | -415,000 | - | -% |
Feb 15, 2024 | State of Wyoming | added | 101 | 44,210 | 79,726 | 0.01% |
Unveiling SWK Holdings Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to SWK Holdings Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
BLK | 111.6B | 17.9B | 20.29 | 6.25 | ||||
BX | 87.1B | 8.0B | 62.62 | 10.86 | ||||
BK | 40.7B | 20.6B | 12.4 | 1.97 | ||||
ARES | 40.3B | 3.6B | 84.87 | 11.08 | ||||
BEN | 13.0B | 7.9B | 13.43 | 1.65 | ||||
MID-CAP | ||||||||
IVZ | 6.8B | 5.7B | -20.45 | 1.19 | ||||
AMG | 5.2B | 2.1B | 7.79 | 2.55 | ||||
AB | 3.7B | - | 14.14 | - | ||||
APAM | 3.4B | 975.1M | 15.27 | 3.48 | ||||
CNS | 3.3B | 489.6M | 25.91 | 6.83 | ||||
AMK | 2.6B | 708.5M | 21.25 | 3.69 | ||||
SMALL-CAP | ||||||||
PX | 870.6M | 241.7M | -126.51 | 3.6 | ||||
BSIG | 868.5M | 426.6M | 13.2 | 2.04 | ||||
AINC | 16.4M | 746.8M | -3.54 | 0.02 | ||||
AC | 695.9K | 25.3M | 0.02 | 0.03 |
SWK Holdings Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 10.4% | 10.00 | 9.00 | 9.00 | 9.00 | 10.00 | 14.00 | 12.00 | 11.00 | 11.00 | 10.00 | 10.00 | 9.00 | 9.00 | 8.00 | 7.00 | 7.00 | 6.00 | 6.00 | 9.00 | 7.00 | 6.00 |
Costs and Expenses | 92.4% | -0.33 | -4.33 | -4.67 | -5.32 | 4.00 | -6.76 | -1.74 | -5.29 | -49.89 | 7.00 | 6.00 | 6.00 | 8.00 | 9.00 | 8.00 | 9.00 | 3.00 | 1.00 | 2.00 | 1.00 | 14.00 |
S&GA Expenses | -8.8% | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 4.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 | 2.00 | 3.00 | 3.00 | 2.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 |
R&D Expenses | -0.7% | 1.00 | 1.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | 0.00 | - | - | - | - |
EBITDA Margin | 49.9% | 0.50* | 0.34* | 0.44* | 0.31* | 0.30* | 0.56* | 0.40* | 0.70* | 0.67* | 0.66* | 0.80* | 0.53* | 0.44* | - | - | - | - | - | - | - | - |
Interest Expenses | 540.9% | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Taxes | -478.5% | -2.23 | -0.39 | 1.00 | -0.11 | -7.21 | 2.00 | 0.00 | 1.00 | 2.00 | 1.00 | 4.00 | 1.00 | -1.34 | -1.00 | 1.00 | -8.16 | -0.61 | 1.00 | 1.00 | -0.36 | -1.70 |
Earnings Before Taxes | -85.1% | 1.00 | 4.00 | 5.00 | 5.00 | -4.38 | 9.00 | 1.00 | 5.00 | 8.00 | 3.00 | 17.00 | 4.00 | 3.00 | -0.12 | -3.41 | 1.00 | 4.00 | 5.00 | 8.00 | 4.00 | -7.41 |
EBT Margin | 55.6% | 0.39* | 0.25* | 0.36* | 0.23* | 0.23* | 0.49* | 0.34* | 0.63* | 0.59* | 0.54* | 0.63* | 0.27* | 0.10* | - | - | - | - | - | - | - | - |
Net Income | -36.4% | 3.00 | 4.00 | 4.00 | 5.00 | 3.00 | 7.00 | 1.00 | 3.00 | 6.00 | 2.00 | 14.00 | 3.00 | 5.00 | 1.00 | -4.66 | 9.00 | 4.00 | 4.00 | 7.00 | 5.00 | -5.72 |
Net Income Margin | 2.5% | 0.42* | 0.41* | 0.45* | 0.36* | 0.33* | 0.38* | 0.26* | 0.50* | 0.46* | 0.47* | 0.57* | 0.32* | 0.14* | - | - | - | - | - | - | - | - |
Free Cashflow | 49.1% | 6.00 | 4.00 | 5.00 | 1.00 | 3.00 | 2.00 | -0.86 | 4.00 | 11.00 | 4.00 | 15.00 | 4.00 | 8.00 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 5.8% | 334 | 316 | 290 | 301 | 300 | 292 | 284 | 286 | 283 | 277 | 273 | 277 | 274 | 257 | 259 | 265 | 254 | 248 | 225 | 221 | 216 |
Current Assets | -68.1% | 12.00 | 37.00 | 13.00 | 9.00 | 10.00 | 28.00 | 59.00 | 46.00 | 47.00 | 25.00 | 13.00 | 7.00 | 7.00 | 17.00 | 23.00 | 29.00 | 16.00 | - | - | - | 23.00 |
Cash Equivalents | -85.5% | 5.00 | 31.00 | 7.00 | 3.00 | 6.00 | 19.00 | 55.00 | 41.00 | 43.00 | 19.00 | 7.00 | 2.00 | 3.00 | 9.00 | 17.00 | 24.00 | 11.00 | 4.00 | 27.00 | 39.00 | 20.00 |
Net PPE | -0.7% | 5.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 3.00 | 3.00 | 1.00 | 1.00 | 1.00 | - | - | 0.00 |
Goodwill | -100.0% | - | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 5.00 | - | - | - |
Liabilities | 40.9% | 54.00 | 38.00 | 17.00 | 26.00 | 20.00 | 15.00 | 13.00 | 15.00 | 15.00 | 16.00 | 15.00 | 33.00 | 33.00 | 21.00 | 27.00 | 33.00 | 18.00 | 20.00 | 1.00 | 2.00 | 3.00 |
Current Liabilities | -84.1% | 4.00 | 25.00 | 3.00 | 12.00 | 6.00 | 5.00 | 3.00 | 5.00 | 5.00 | 5.00 | 3.00 | 15.00 | 15.00 | 4.00 | 9.00 | 18.00 | 3.00 | - | - | - | 3.00 |
Shareholder's Equity | 1.0% | 280 | 278 | 274 | 274 | 280 | 277 | 272 | 271 | 267 | 261 | 258 | 244 | 241 | 236 | 232 | 232 | 237 | 228 | 223 | 219 | 213 |
Retained Earnings | 0.1% | -4,144 | -4,147 | -4,152 | -4,156 | -4,151 | -4,153 | -4,160 | -4,161 | -4,164 | -4,170 | -4,173 | -4,187 | -4,190 | -4,195 | -4,199 | -4,200 | -4,195 | -4,204 | -4,208 | -4,212 | -4,219 |
Additional Paid-In Capital | 0.0% | 4,425 | 4,425 | 4,426 | 4,430 | 4,431 | 4,431 | 4,432 | 4,432 | 4,432 | 4,431 | 4,431 | 4,431 | 4,431 | 4,431 | 4,431 | 4,432 | 4,432 | 4,432 | 4,432 | 4,432 | 4,432 |
Shares Outstanding | -0.1% | 12.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | 58.00 | - | - | - | 64.00 | - | - | - | 61.00 | - | - | - | 43.00 | - | - | - | 36.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 50.0% | 5,700 | 3,799 | 4,724 | 664 | 2,924 | 1,770 | -803 | 4,311 | 11,223 | 3,822 | 14,879 | 4,371 | 10,059 | 4,075 | 1,817 | 3,317 | 5,142 | 2,535 | 3,859 | 7,000 | 4,660 |
Share Based Compensation | -17.6% | 140 | 170 | 164 | 35.00 | 190 | 59.00 | 166 | 85.00 | 607 | 192 | 187 | 177 | 179 | 179 | 183 | 187 | 193 | 147 | 88.00 | 102 | 71.00 |
Cashflow From Investing | -39095.5% | -52,522 | -134 | 14,790 | -11,082 | -15,573 | -36,730 | 14,522 | -5,767 | 15,369 | 8,190 | 7,371 | -5,169 | -26,111 | -4,580 | -92.00 | -4,383 | 1,604 | -25,411 | -15,616 | 12,701 | -2,329 |
Cashflow From Financing | 2.2% | 21,023 | 20,564 | -15,953 | 7,506 | -594 | -759 | - | -8.00 | -2,368 | 8.00 | -17,241 | -600 | 9,746 | -7,348 | -8,876 | 14,226 | -74.00 | -11.00 | -53.00 | -745 | -1,318 |
Buy Backs | -75.7% | 234 | 963 | 4,599 | 531 | 539 | 599 | - | - | - | - | - | - | 12.00 | 903 | 1,033 | 62.00 | 74.00 | 11.00 | 53.00 | 745 | - |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenues: | ||
Finance receivable interest income, including fees | $ 36,346 | $ 35,461 |
Pharmaceutical development | 1,202 | 5,485 |
Other | 212 | 538 |
Total revenues | 37,760 | 41,484 |
Costs and expenses: | ||
Allowance for credit losses | 1,912 | 3,491 |
Impairment of goodwill | 8,404 | |
Interest expense | 1,849 | 340 |
Pharmaceutical manufacturing, research and development expense | 3,436 | 6,952 |
General and administrative | 11,232 | 12,964 |
Change in fair value of acquisition-related contingent consideration | (6,300) | 5,170 |
Depreciation and amortization expense | 2,577 | 2,599 |
Income from operations | 14,650 | 9,968 |
Other income (expense), net | ||
Unrealized net (loss) gain on warrants | (55) | 417 |
Unrealized net loss on equity securities | (528) | |
Realized loss from sale of investments | (799) | (151) |
Foreign currency transaction gain (loss) | 817 | (215) |
Income before income tax benefit | 14,613 | 9,491 |
Income tax benefit | (1,274) | (4,000) |
Net income | $ 15,887 | $ 13,491 |
Net income per share | ||
Basic | $ 1.26 | $ 1.05 |
Diluted | $ 1.25 | $ 1.05 |
Basic | 12,653,000 | 12,835,000 |
Diluted | 12,696,000 | 12,880,000 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 4,503 | $ 6,156 |
Restricted cash | 733 | |
Interest and accounts receivable, net | 4,729 | 3,094 |
Other current assets | 1,904 | 1,114 |
Total current assets | 11,869 | 10,364 |
Finance receivables, net | 274,504 | 236,555 |
Collateral on foreign currency forward contract | 2,750 | 2,750 |
Marketable investments | 48 | 76 |
Deferred tax assets, net | 28,290 | 24,480 |
Warrant assets | 1,759 | 1,220 |
Goodwill | 8,404 | |
Intangible assets, net | 6,487 | 8,190 |
Property and equipment, net | 5,438 | 5,840 |
Other non-current assets | 3,109 | 1,742 |
Total assets | 334,254 | 299,621 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 3,944 | 3,902 |
Revolving credit facility | 2,445 | |
Total current liabilities | 3,944 | 6,347 |
Contingent consideration payable | 4,900 | 11,200 |
Unsecured senior notes, net | 30,781 | |
Revolving credit facility | 12,350 | |
Other non-current liabilities | 1,964 | 2,145 |
Total liabilities | 53,939 | 19,692 |
Stockholders’ equity: | ||
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | ||
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,497,770 and 12,843,157 shares issued and outstanding at December 31, 2023 and 2022, respectively | 12 | 12 |
Additional paid-in capital | 4,425,104 | 4,430,922 |
Accumulated deficit | (4,144,801) | (4,151,005) |
Total stockholders’ equity | 280,315 | 279,929 |
Total liabilities and stockholders’ equity | $ 334,254 | $ 299,621 |